These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 14656921)

  • 41. Angiotensin-converting enzyme inhibition increases basal vascular tissue plasminogen activator release in women but not in men.
    Pretorius M; Luther JM; Murphey LJ; Vaughan DE; Brown NJ
    Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2435-40. PubMed ID: 16166566
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term angiotensin-converting enzyme inhibitor treatment attenuates adrenergic responsiveness without altering hemodynamic control in patients undergoing cardiac surgery.
    Licker M; Neidhart P; Lustenberger S; Valloton MB; Kalonji T; Fathi M; Morel DR
    Anesthesiology; 1996 Apr; 84(4):789-800. PubMed ID: 8638832
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stimulated in vivo synthesis of plasminogen activator inhibitor-1 in human adipose tissue.
    Ekström M; Liska J; Eriksson P; Sverremark-Ekström E; Tornvall P
    Thromb Haemost; 2012 Sep; 108(3):485-92. PubMed ID: 22740034
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Is cardiopulmonary bypass a reason for aspirin resistance after coronary artery bypass grafting?
    Zimmermann N; Kurt M; Wenk A; Winter J; Gams E; Hohlfeld T
    Eur J Cardiothorac Surg; 2005 Apr; 27(4):606-10. PubMed ID: 15784358
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery.
    Collard CD; Body SC; Shernan SK; Wang S; Mangano DT; ;
    J Thorac Cardiovasc Surg; 2006 Aug; 132(2):392-400. PubMed ID: 16872968
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Peritoneal fibrinolytic response to various aspects of laparoscopic surgery: a randomized trial.
    Brokelman WJ; Holmdahl L; Bergström M; Falk P; Klinkenbijl JH; Reijnen MM
    J Surg Res; 2006 Dec; 136(2):309-13. PubMed ID: 17054995
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differences in angiotensin convertase enzyme (ACE) activity and expression may contribute to shorter event free period after coronary artery bypass graft surgery.
    Daragó A; Fagyas M; Siket IM; Facskó A; Megyesi Z; Kalász J; Galajda Z; Szerafin T; Hársfalvi J; Edes I; Papp Z; Tóth A; Szentmiklósi J
    Cardiovasc Ther; 2012 Jun; 30(3):136-44. PubMed ID: 21106034
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pump blood processing, salvage and re-transfusion improves hemoglobin levels after coronary artery bypass grafting, but affects coagulative and fibrinolytic systems.
    Scrascia G; Rotunno C; Nanna D; Rociola R; Guida P; Rubino G; de Luca Tupputi Schinosa L; Paparella D
    Perfusion; 2012 Jul; 27(4):270-7. PubMed ID: 22440640
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Changes in hemostasis during pediatric heart surgery: impact of a biocompatible heparin-coated perfusion system.
    Jensen E; Andréasson S; Bengtsson A; Berggren H; Ekroth R; Larsson LE; Ouchterlony J
    Ann Thorac Surg; 2004 Mar; 77(3):962-7. PubMed ID: 14992907
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of laparoscopic and conventional colorectal resection on peritoneal fibrinolytic capacity: a prospective randomized clinical trial.
    Neudecker J; Junghans T; Ziemer S; Raue W; Schwenk W
    Int J Colorectal Dis; 2002 Nov; 17(6):426-9. PubMed ID: 12355220
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Heparin-coated bypass circuits (Carmeda) suppress the release of tissue plasminogen activator during normothermic coronary artery bypass graft surgery.
    Spiess BD; Vocelka C; Cochran RP; Soltow L; Chandler WL
    J Cardiothorac Vasc Anesth; 1998 Jun; 12(3):299-304. PubMed ID: 9636912
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of sodium nitroprusside infusion on renal function during reperfusion period in patients undergoing coronary artery bypass grafting: a prospective randomized clinical trial.
    Kaya K; Oğuz M; Akar AR; Durdu S; Aslan A; Erturk S; Taşöz R; Ozyurda U
    Eur J Cardiothorac Surg; 2007 Feb; 31(2):290-7. PubMed ID: 17174559
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of cell saver autologous blood transfusion on blood loss and homologous blood transfusion requirements in patients undergoing cardiac surgery on- versus off-cardiopulmonary bypass: a randomised trial.
    Niranjan G; Asimakopoulos G; Karagounis A; Cockerill G; Thompson M; Chandrasekaran V
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):271-7. PubMed ID: 16829083
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Angiotensin-converting enzyme inhibition in patients with coronary artery disease and preserved left ventricular function Ischemia Management with Accupril post-bypass graft via inhibition of angiotensin-converting enzyme (IMAGINE) compared with the other major trials in coronary artery disease.
    van Gilst WH; Warnica JW; Baillot R; Johnstone D; Calciu CD; Block P; Myers MG; Chocron S; Rouleau JL;
    Am Heart J; 2006 Jun; 151(6):1240-6. PubMed ID: 16781228
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of angiotensin-converting enzyme inhibitor on hemodynamic instability in patients undergoing cardiopulmonary bypass: results of a dose-comparison study.
    Shahzamani M; Yousefi Z; Frootaghe AN; Jafarimehr E; Froughi M; Tofighi F; Azadani AN; Pourhoseingholi MA; Azadani PN
    J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):185-91. PubMed ID: 19721131
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-1.
    Brown NJ; Agirbasli MA; Williams GH; Litchfield WR; Vaughan DE
    Hypertension; 1998 Dec; 32(6):965-71. PubMed ID: 9856958
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Measurement of plasminogen activator system components in plasma and tumor tissue extracts obtained from patients with breast cancer: an EORTC Receptor and Biomarker Group collaboration.
    Grebenchtchikov N; Maguire TM; Riisbro R; Geurts-Moespot A; O'Donovan N; Schmitt M; McGreal G; McDermott E; O'Higgins N; Brünner N; Sweep CG; Duffy MJ
    Oncol Rep; 2005 Jul; 14(1):235-9. PubMed ID: 15944795
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bradykinin decreases plasminogen activator inhibitor-1 expression and facilitates matrix degradation in the renal tubulointerstitium under angiotensin-converting enzyme blockade.
    Okada H; Watanabe Y; Kikuta T; Kobayashi T; Kanno Y; Sugaya T; Suzuki H
    J Am Soc Nephrol; 2004 Sep; 15(9):2404-13. PubMed ID: 15339989
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Response of visceral peritoneum to abdominal surgery.
    Ivarsson ML; Falk P; Holmdahl L
    Br J Surg; 2001 Jan; 88(1):148-51. PubMed ID: 11136330
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Postoperative bleeding in cardiac surgery: the role of tranexamic acid in patients homozygous for the 5G polymorphism of the plasminogen activator inhibitor-1 gene.
    Iribarren JL; Jimenez JJ; Hernández D; Brouard M; Riverol D; Lorente L; de La Llana R; Nassar I; Perez R; Martinez R; Mora ML
    Anesthesiology; 2008 Apr; 108(4):596-602. PubMed ID: 18362590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.